Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Surg Oncol ; 23(7): 2212-9, 2016 07.
Article in English | MEDLINE | ID: mdl-27020588

ABSTRACT

BACKGROUND: Desmoid tumors (DT) occur sporadically, in familial adenomatous polyposis, or in association with pregnancy. Initial observation has been proposed in the management of DT. An advantage of this approach is to select patients who have indolent disease versus those who require intervention. Here we report our multidisciplinary experience of abdominal DT as it relates to nonoperative management. METHODS: Patients seeking care from 1980 to 2012 with pathologically confirmed DT were identified from clinical research databases. Clinicopathologic data and management strategies were collected, and statistical analyses were performed by Chi square and t tests. RESULTS: A total of 213 patients were identified; DT occurred in abdominal wall (n = 103, 48 %), intra-abdominally (n = 92, 43 %), or at both sites (n = 18, 9 %). Patients were predominantly female (72 %); disease was sporadic (48 %), associated with familial adenomatous polyposis (38 %), or associated with pregnancy (14 %). Patient presentation was stratified into 3 groups: untreated (group A; n = 176), DT resected elsewhere (group B; n = 19), or recurrent DT (group C; n = 18). In group A, 109 patients were initially observed, with 51 patients requiring intervention as a result of progression or symptoms. Of the 58 patients who underwent only observation, 93 % experienced spontaneous regression or stable disease (median follow-up 38 months). Of the 67 patients in group A who underwent resection, 28 % experienced recurrence (median 22 months). Abdominal wall DT >7 cm and intra-abdominal DT were more likely to recur (P < 0.01). CONCLUSIONS: Initial observation has been implemented for abdominal DT at our institution. Over half of patients observed required no intervention with prolonged follow-up. Tumor size and site may predict progression during observation, therefore representing higher-risk groups.


Subject(s)
Adenomatous Polyposis Coli/surgery , Fibromatosis, Abdominal/surgery , Observation , Adenomatous Polyposis Coli/complications , Adenomatous Polyposis Coli/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Disease Management , Disease Progression , Female , Fibromatosis, Abdominal/complications , Fibromatosis, Abdominal/pathology , Follow-Up Studies , Humans , Male , Middle Aged , Pregnancy , Prognosis , Young Adult
2.
Head Neck ; 36(2): 286-90, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23508631

ABSTRACT

Therapeutic central neck dissection for differentiated thyroid cancer is recommended in the setting of clinically positive disease. The role of lymphadenectomy in patients with clinically negative disease is a matter of controversy and therefore extent of surgery varies. The boundaries of the central neck are variably described, as are the components of a central neck dissection. Patients with aggressive disease are managed with a comprehensive dissection, yet there is no classification system to distinguish this from a less rigorous operation. Therefore, there is variability in reporting and difficulty in the interpretation of results in the published literature. Here we propose a novel classification system for central neck dissection in thyroid cancer that allows accurate reporting of extent of surgery. The objectives are to reduce ambivalence and allow documentation of extent of lymphadenectomy, such that comparisons can be made between the varied strategies in the management of the central compartment.


Subject(s)
Carcinoma, Medullary/surgery , Carcinoma, Papillary/surgery , Neck Dissection/classification , Thyroid Neoplasms/surgery , Thyroidectomy , Carcinoma, Medullary/pathology , Carcinoma, Papillary/pathology , Evidence-Based Medicine , Humans , Meta-Analysis as Topic , Neck Dissection/methods , Practice Guidelines as Topic , Thyroid Neoplasms/pathology , Thyroidectomy/methods , Treatment Outcome
3.
Can J Physiol Pharmacol ; 82(12): 1128-34, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15644956

ABSTRACT

Adipocytes are the primary source of circulating leptin. Leptin inhibits eating, increases metabolism, and stimulates the reproductive axis. Numerous hypothalamic neuropeptides have been implicated in leptin's behavioral and neuroendocrine effects, including neuropeptide Y (NPY) and cocaine- and amphetamine-regulated transcript (CART). The aim of this study was to investigate the physiological relevance of leptin's signaling of nutritional status by comparing the effects of leptin with the effects of re-feeding on fasting-induced changes in the expression of the long form of the leptin receptor (Ob-Rb), NPY, and CART. Adult male rats were fasted for 48 h and treated with either intracerebroventricular (i.c.v.) or subcutaneous (s.c.) leptin throughout the fast, or fed ad libitum for 24 h after terminating the fast. Expression of NPY, Ob-Rb, and CART mRNA in the arcuate nucleus (ARC) was determined by in situ hybridization histochemistry and compared with vehicle-treated fed or fasted controls. Fasting increased NPY and Ob-Rb expression and decreased CART expression in the ARC. Leptin (regardless of route) and re-feeding were equally effective in normalizing CART mRNA expression. A similar trend was observed with Ob-Rb expression. In contrast, neither re-feeding nor s.c. leptin reversed the increased expression of NPY that was induced by fasting. Only i.c.v. leptin was effective in this regard. Our results indicate leptin and re-feeding are equally effective in normalizing fasting-induced changes in CART and Ob-Rb expression, but less effective in normalizing NPY expression. These results suggest that leptin is the primary nutritional signal regulating CART and Ob-Rb expression in the ARC, and highlight potential differences between CART and NPY neuron sensitivity to leptin signaling.


Subject(s)
Eating/physiology , Fasting/physiology , Hypothalamus/physiology , Leptin/pharmacology , Neuropeptides/biosynthesis , Animals , Appetite/physiology , Body Weight/physiology , Cell Count , Gene Expression/drug effects , Hypothalamus/drug effects , In Situ Hybridization , Lateral Ventricles/physiology , Male , Nerve Tissue Proteins/metabolism , Neuropeptide Y/metabolism , Neuropeptides/genetics , Perfusion , RNA, Complementary/biosynthesis , RNA, Complementary/genetics , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...